The Asia Pacific Light Therapy Market would witness market growth of 5.4% CAGR during the forecast period (2022-2028).
Light therapy is also used to treat non-seasonal depression. According to the Cochrane Collaboration's meta-analysis, light treatment shows small but potential antidepressive efficacy for people suffering from non-seasonal depression. In general, light therapy is an ideal candidate for integration into the therapeutic inventory currently available for non-seasonal depression treatment as an adjuvant treatment to antidepressant medication.
In addition, it may eventually be used as a stand-alone therapy treatment for particular groups of depressed patients, according to a 2008 systematic review. The time of light exposure is crucial in the treatment of circadian rhythm disorders like delayed sleep phase disorder (DSPD).
The phase response curve can be influenced by light exposure given to the eyes after or before the nadir of the basic body temperature rhythm. Use of light therapy after awakening could be helpful for sleep disorders that don't last 24 hours. Lights that come on just before waking up have been successful for some individuals (dawn simulation). For patients with advanced sleep phase disorders, evening use is advised. Light therapy may also help some fully blind patients with intact retinas.
The rapid growth rate can be credited for an increase in preterm births and a rise in the number of people with skin conditions. For instance, according to The Lancet, majority of late preterm births take place in Asia and South Asia, accounting for a substantial proportion of all preterm births. Furthermore, 1/5th of the preterm births that occur worldwide occur in India alone. Additionally, acne is common in the Asia Pacific region, which is projected to increase demand for phototherapy equipment. For instance, the Derma Health Institute reports that acne is a widespread issue for persons of Asian ancestry, which is driving the market for light therapy in this region.
The China market dominated the Asia Pacific Light Therapy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $102.4 million by 2028. The Japan market is estimated to grow a CAGR of 4.7% during (2022 - 2028). Additionally, The India market would display a CAGR of 6% during (2022 - 2028).
Based on End-use, the market is segmented into Home Healthcare and Dermatology Clinics. Based on Application, the market is segmented into Sleeping Disorders, Eczema & Acne Vulgaris, Psoriasis, Vitiligo and Others. Based on Light Type, the market is segmented into Blue Light, Red Light and White Light. Based on Product, the market is segmented into Handheld Devices for Skin Treatment, Floor & Desk Lamps, Light Box, Light Therapy Lamps, Light Visor and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Light Therapy Market is Projected to reach USD 1.2 Billion by 2028, at a CAGR of 4.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Beurer GmBH, Johnson & Johnson, Koninklijke Philips N.V., Biophotas, Inc. (Celluma), Nature Bright Company, Outside In (Cambridge) Ltd. (Lumie), Northern Light Technologies, Inc., Verilux, Inc. (Bear Down Brands, LLC), The Daylight Company Limited, and Theralight LLC.
By End-use
By Application
By Light Type
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 